Navigation Links
STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
Date:1/14/2010

ere randomized to receive subcutaneously administered STELARA or etanercept.  Patients randomized to receive STELARA received 45 mg or 90 mg doses at weeks 0 and 4.  Patients in the etanercept group received twice-weekly doses of 50 mg for 12 weeks.  The primary endpoint of the study was the proportion of patients who achieved PASI 75 at week 12.  At week 12, patients in the etanercept group who were classified as non-responders (i.e., had moderate, marked or severe psoriasis) received 90 mg of STELARA at weeks 16 and 20.  STELARA non-responders received one additional dose of STELARA at week 16.  Treatment was interrupted for all patients who had cleared, minimal or mild psoriasis at the end of week 12, and all patients were retreated with 45 or 90 mg STELARA when their disease worsened to moderate or worse.  

About Psoriasis

Psoriasis is a chronic, immune-mediated disease that results from the overproduction of skin cells, resulting in their accumulation on the surface of the skin, which causes red, scaly plaques that may itch and bleed.  It is estimated that approximately 7.5 million people in the United States are living with psoriasis and nearly one-quarter of those people have cases that are considered moderate to severe.

About STELARA (ustekinumab)

STELARA, a human interleukin (IL)-12 and IL-23 antagonist, is approved for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.  IL-12 and IL-23 are naturally occurring proteins that are believed to play a role in psoriasis.  For more information about STELARA, visit

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 27, 2015 Research and Markets ( ... "Global Neurostimulation Devices Market 2015" report ... the global neurostimulation devices market to grow at ... The report, Global Neurostimulation Devices Market ... market analysis with inputs from industry experts. The ...
(Date:7/29/2015)... a privately-held regenerative medicine company with the first stem cell-derived islet ... announced the opening of a second site in its Phase 1/2 ... and E fficacy of VC-01™ Combination P roduct in ... first in Canada , will be at the ... The lead Edmonton investigator ...
(Date:7/29/2015)... , July 29, 2015  Fifty groups representing ... Wednesday, July 29, to launch the AllTrials campaign in ... trial, past, present, and future, to be registered and ... co-founder Dr Ben Goldacre explains: "Patients want ... good quality evidence on what works. Unfortunately, we now ...
Breaking Medicine Technology:Global Neurostimulation Devices Market 2015-2019 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... Data published in BMC Cancer and PLoS ... highly differentiated diagnosis from blood samples for lung cancer and ... patient tissue samples may become obsolete in the coming years. ... at the University of Saarland (Germany) investigated the performance of ...
... , DALLAS, Oct. 13 Eclipsemed Ltd, a leading ... announced its recent partnership with Human Med USA. ... medical and aesthetic devices including the revolutionary Body-Jet®, has ... increase efforts to sell Body-Jet® in the United States ...
Cached Medicine Technology:MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 2Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R) 2
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... ... Petitions were approved by USCIS over the past month! I-829 approvals have been granted ... projects in Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired ... Foundation in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative ... patients with demonstrated financial need. , “We are thrilled for this opportunity to ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces ... the general contact information, website, types of plans administered, years in business, and credentials ... and have at least one plan with Employee Fiduciary. A search can be done ...
(Date:7/29/2015)... ... ... TransFlip is an all new dynamic transition pack for FCPX, containing flipping ... are easy to apply and modify for any skill-level user. TransFlip includes custom bounce ... kinetic flipping panel animations are just a few clicks away. , TransFlip contains over ...
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native ... late 1970s, Dr. Cottrell has been making predictions about the economy, politics, social ... many of these prognostications. He warns that extreme weather conditions and increased earthquake ...
Breaking Medicine News(10 mins):Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
... have discovered that activation of a particular brain region ... The results of this Duke University Medical Center study ... of Nature Neuroscience. ,"Although understanding the ... what drives people like Mother Theresa, it may give ...
... growing number of youngsters are contracting tuberculosis, especially those in ... excessive weight loss, according to a report. ... in their 20s. ,According to the report ... people contracted tuberculosis in 2006, an average of 115 people ...
... how beneficial traits shape up in natural populations,// but one ... costly traits. Two theories have tried to address this challenge ... selection. ,The theory of hitchhiking has indicated ... become frequent in natural populations when they "hitch a ride" ...
... that has left its victims stoned. , Federal agents ... producing establishments Wednesday. The raids are the biggest raids to ... than 5000 pounds of pot (marijuana), as well as pot-laced ... According to the pot retailers, which include marijuana medical clinic ...
... research that does not bark up the wrong tree. ,According to ... //evidence to back the fact that owning a dog is indeed ... in lower blood pressure and cholesterol, it reduces the occurrence of ... problems. This could be attributed to the positive impact of owning ...
... Novartis bagged the contract to make a chemical that ... million contract// was finalised on Wednesday. ,The ... contracts to fight a possible bird-flu outbreak in humans. ... on Wednesday by the U.S. Department of Health and ...
Cached Medicine News:Health News:Activation of a Particular Brain Region Predicts Altruism: Study 2Health News:More Youngsters Get Tuberculosis 2Health News:The Evolution of Costly Traits 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: